These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24305748)

  • 41. Endometrial thickness after misoprostol use for early pregnancy failure.
    Creinin MD; Harwood B; Guido RS; Fox MC; Zhang J;
    Int J Gynaecol Obstet; 2004 Jul; 86(1):22-6. PubMed ID: 15207665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage.
    Niinimäki M; Jouppila P; Martikainen H; Talvensaari-Mattila A
    Fertil Steril; 2006 Aug; 86(2):367-72. PubMed ID: 16764872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical treatment of second-trimester fetal miscarriage; A retrospective analysis.
    Niinimäki M; Mentula M; Jahangiri R; Männistö J; Haverinen A; Heikinheimo O
    PLoS One; 2017; 12(7):e0182198. PubMed ID: 28753654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bleeding pattern after medical management of early pregnancy loss with mifepristone-misoprostol and its prognostic value: a prospective observational cohort study.
    Enzelsberger SH; Wetzlmair D; Hermann P; Wagner H; Shebl O; Oppelt P; Trautner PS
    Arch Gynecol Obstet; 2022 Aug; 306(2):349-355. PubMed ID: 34694431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of misoprostol in relation to uterine position in the treatment of early pregnancy failure.
    Reif P; Tappauf C; Panzitt T; Haas J; Lang U; Klaritsch P
    Int J Gynaecol Obstet; 2013 May; 121(2):137-40. PubMed ID: 23419998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study.
    Avraham S; Gat I; Duvdevani NR; Haas J; Frenkel Y; Seidman DS
    Fertil Steril; 2012 Mar; 97(3):612-5. PubMed ID: 22265034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Success And Safety Of Misoprostol For Treatment Of Early Pregnancy Failure.
    Nazir Q; Habib S; Sultana R; Noor MM; Parveen Z
    J Ayub Med Coll Abbottabad; 2018; 30(2):245-247. PubMed ID: 29938428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial.
    Goel A; Mittal S; Taneja BK; Singal N; Attri S
    Arch Gynecol Obstet; 2011 Jun; 283(6):1409-13. PubMed ID: 21431329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination.
    Nissi R; Santala M; Immonen E; Talvensaari-Mattila A
    Arch Gynecol Obstet; 2016 Nov; 294(6):1243-1247. PubMed ID: 27522599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020.
    Boos EW; Horta M; Thompson I; Dusetzina SB; Leech AA
    JAMA; 2023 Aug; 330(8):766-3. PubMed ID: 37477929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
    Dahiya K; Mann S; Nanda S
    Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The MISOPRED score: Development and validation of a clinical scoring system to predict the effectiveness of Misoprostol treatment for early pregnancy loss.
    Bar-Noy T; Limonad O; Gandelsman E; Shrim A; Sharabi H; Zarecki R; Hallak M; Bruchim I
    PLoS One; 2024; 19(5):e0303607. PubMed ID: 38820313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8 and 16 weeks of gestation].
    Qian J; Jing X; Wu S; Zheng S; Li Y; Ren M; Di W; Shen H; Dong B; Chang Q; Shi H; Yao C; Song W; Huang Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):505-9. PubMed ID: 26311640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
    Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
    Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation.
    Fiala C; Swahn ML; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2005 Nov; 20(11):3072-7. PubMed ID: 16055455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
    Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.